The U. S. Department of Justice announced today that agriculture giant Bayer CropScience LLC has removed several ...
Bayer announced today that the U.S. Food and Drug Administration (FDA) accepted its supplemental New Drug Application (sNDA) and granted Priority Review designation for KERENDIA ® (finerenone), which ...
Bayer said on Thursday that the U.S. Food and Drug Administration had accepted its supplemental New Drug Application for ...
Zacks Investment Research on MSN
Bayer gets FDA priority review for asundexian NDA in stroke prevention
Bayer BAYRY announced that the FDA has accepted its new drug application (NDA) for its investigational, once-daily, oral ...
Bayer CropScience LLC has removed potentially anticompetitive provisions from its loyalty program, the Justice Department says in a statement.
Centered around a glaucoma therapy in mid-stage testing, the deal is Bayer’s first drug company acquisition in several years ...
FRANKFURT, Feb 18 (Reuters) - Bayer's shares slumped as much as 12% on Wednesday, wiping out the previous day's gains, as investors questioned whether a proposed $7.25 billion settlement of cancer ...
Abstracts: 512 | 2517 | 3096 | 3145 | 4500 | 5005 | 5039 | 5083 | 5095 | 5103 | 6012 | 8618 | 8622 | 10036 | 11164 | e15604 | ...
Bayer has appealed a verdict awarding $1.25M to a man who was diagnosed with non-Hodgkin lymphoma after years of exposure to glyphosate in Roundup.
Heading into the second half of their 2025 financial year, Bayer leaders echo positive comments surrounding the company’s crop science division. What has them bullish? First, Bayer is optimistic the ...
By Dietrich Knauth NEW YORK, May 18 (Reuters) - Bayer’s Monsanto unit on Monday said it would pay at least $133 million to ...
The US Supreme Court gave Bayer AG a mixed reception on its bid to stop tens of thousands of lawsuits claiming its Roundup herbicide should have been labeled as a cancer risk.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results